Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study

Autor: José González-Costello, Josep Comín-Colet, Josep Lupón, Cristina Enjuanes, Marta de Antonio, Lara Fuentes, Pedro Moliner-Borja, Nuria Farré, Elisabet Zamora, Nicolás Manito, Ramón Pujol, Antoni Bayés-Genis

Publikováno v: BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-11 (2018)

Abstract Background Iron deficiency (ID) in patients with chronic heart failure (CHF) is considered an adverse prognostic factor. We aimed to evaluate if ID in patients with CHF is associated with increased mortality and hospitalizations. Methods We

Externí odkaz: https://doaj.org/article/f548203330b64bdeb40b9e2f082e98fb

Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settings.

Autor: Capdevila Aguilera, Cristina, Vela Vallespín, Emili, Clèries Escayola, Montse, Yun Viladomat, Sergi, Fernández Solana, Coral, Alcober Morte, Laia, Monterde Prat, David, Hidalgo Quirós, Encarna, Calero Molina, Esther, José Bazán, Núria, Moliner Borja, Pedro, Piera Jiménez, Jordi, Ruiz Muñoz, Marta, Corbella Virós, Xavier, Jiménez-Marrero, Santiago, Garay Melero, Alberto, Ramos Polo, Raúl, Alcoberro Torres, Lidia, Pons Riverola, Alexandra, Enjuanes Grau, Cristina

Publikováno v: Revista Española de Cardiología (18855857); Oct2023, Vol. 76 Issue 10, p803-812, 10p

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients.

Autor: Ras-Jiménez MDM; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Department of Internal Medicine, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., Ramos-Polo R; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., Francesch Manzano J; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain., Corbella Santano M; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain., Morillas Climent H; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., Jose-Bazán N; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., Jiménez-Marrero S; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Garcimartin Cerezo P; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.; Advanced Practice Nurses, Hospital del Mar, Parc de Salut Mar, 08003 Barcelona, Spain.; Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.; Escuela Superior de Enfermería del Mar, Parc de Salut Mar, 08003 Barcelona, Spain., Yun Viladomat S; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Department of Internal Medicine, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Moliner Borja P; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Torres Cardús B; Primary Care Service Delta del Llobregat, Institut Català de la Salut, 08820 Barcelona, Spain., Verdú-Rotellar JM; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.; Primary Care Service Litoral, Institut Català de la Salut, 08023 Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.; Department of Medicine, Universitat Pompeu Fabra, 08002 Barcelona, Spain., Diez-López C; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.; Advanced Heart Failure and Heart Trasplant Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., González-Costello J; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.; Advanced Heart Failure and Heart Trasplant Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., García-Romero E; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.; Advanced Heart Failure and Heart Trasplant Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., de Frutos Seminario F; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Advanced Heart Failure and Heart Trasplant Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., Triguero-Llonch L; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Advanced Heart Failure and Heart Trasplant Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain., Enjuanes Grau C; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Tajes Orduña M; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Comin-Colet J; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.; Department of Clinical Sciences, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.

Publikováno v: Journal of personalized medicine [J Pers Med] 2023 Aug 21; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.